Summary
This prediction ended on 22.11.18 with a price of €62.62. Massive losses of -39.98% were the result for the BUY prediction by tbackenh. tbackenh has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -0.919% | -0.919% | -45.224% | -47.034% |
| iShares Core DAX® | -0.258% | -0.962% | 15.475% | 16.944% |
| iShares Nasdaq 100 | 2.964% | 4.747% | 30.457% | 56.973% |
| iShares Nikkei 225® | 1.217% | 0.285% | 5.780% | 5.634% |
| iShares S&P 500 | 1.732% | 2.635% | 25.189% | 48.524% |
Comments by tbackenh for this prediction
In the thread Bayer AG diskutieren
Bayer
Wie im Langfristchart erkennbar, bewegte sich die Aktie des Chemie- und Pharma-Riesen von Ende 2011 bis April 2015 stetig aufwärts. Danach folgte eine Abwärtsbewegung. 2017 sehen wir eine kleine, volatilere Auf- und Abwärtsphase. Und genau diese könnte durch die Verteidigung des 256-Tage-GD nun zugunsten einer weiteren Aufwärtsbewegung beendet sein.